Sammy Bell, Ph.D.

Adjunct Professor

Sr. Director, External Alternative CMC, Boehringer Ingelheim


United States


Ph.D., Chemistry/Pharmacology, University of Rhode Island, 2017
M.S., Chemistry, University of Rhode Island, 2007
B.S., Chemistry, University of Connecticut, 2002

Professional Experience

  • Boehringer Ingelheim Animal Health (Merial), Duluth, Georgia (Aug 2016 - Present)
  • Alcon Laboratories (Novartis), Johns Creek, Georgia (Nov 2012 - Aug 2016)
  • Pfizer Global Research and Development, Groton Connecticut (2002 - 2012)


  • Process chemistry experience from R&D through late stage manufacturing
  • Pharmaceutical Scientist with expertise from pre-formulation to late stage formulation development (Ph I/II/III) of parenteral and solid oral dosage forms
  • Discovery Chemistry/Research Formulations/Oral Controlled Release/Product Enhancement
  • Drug Delivery and Drug Product Development /Manufacture